Affiliations 

  • 1 Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, 5 Jalan University, Bandar Sunway, Selangor, Malaysia
  • 2 Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia
  • 3 Staff Health Unit, University of Malaya Medical Centre, Jalan Universiti, Lembah Pantai, Kuala Lumpur, Malaysia
  • 4 Department of Family Medicine, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kota Bahru, Kelantan, Malaysia
  • 5 Jalan Masjid Health Clinic, Jalan Masjid, Kuching, Sarawak, Malaysia
  • 6 Padang Rengas Health Clinic, Padang Rengas, Taiping, Perak, Malaysia
  • 7 Department of Family Medicine, International Medical University, Jalan Dr Muthu, Bukit Rasah, Seremban, Negeri Sembilan, Malaysia
  • 8 Sarikei Health Clinic, Bandar Sarikei, Sarikei, Sarawak, Malaysia
  • 9 Segamat Health Clinic, Jalan Muar, 85000Segamat, Johor, Malaysia
  • 10 Department of Family Medicine, Kulliyah of Medicine, International Islamic University Malaysia, Bandar Indera Mahkota Campus, Jalan Sultan Ahmad Shah, Kuantan Pahang, Malaysia
  • 11 Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK
Eur Heart J Suppl, 2019 Apr;21(Suppl D):D77-D79.
PMID: 31043885 DOI: 10.1093/eurheartj/suz061

Abstract

Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. However there are still many individuals, particularly in many countries in Asia, who have poor BP control. In Malaysia, less than two-fifths have achieved BP control. We participated in BP screening in Malaysia in conjunction with the May Measurement Month 2017 (MMM17), a global initiative by the International Society of Hypertension (ISH) aimed at screening more individuals for earlier detection of hypertension. A nationwide screening of adults aged ≥18 was carried out through health campaigns at clinics, hospitals, during family day events, and charity runs from 1 April 2017 to 31 May 2017 in 42 centres. We used the detailed protocol provided by ISH for data collection. A total of 4116 individuals were screened during MMM17. After multiple imputation, 32.4% (n = 1317/4059) had hypertension. Out of this, 63.9% (842/1317) of those with hypertension were on treatment. Of individuals receiving antihypertensive medication with an imputed BP, 59.5% (n = 496/834) of them had controlled BP. MMM17 was the largest organized BP screening campaign undertaken by health professionals in Malaysia. This study identified that 32.4% of screened individuals had hypertension and 59.5% individuals with treated hypertension had achieved BP control.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.